Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
New treatment options are critical for treatment-experienced HIV infected patients with drug resistance. HIV entry inhibitors have been shown effective in patients with resistance to other anti-HIV drugs. This study will test the safety and anti-HIV activity of eight different doses of the HIV entry inhibitor AMD11070 (also known as AMD070) in HIV infected patients.
Epistemonikos ID: f8ceaf9d08dec44c73ea50b4320ba345b138c993
First added on: May 04, 2024